Search Within

Guido Dalbagni

Formats
  1. Journal Article (228)
  2. Meeting Abstract (79)
  3. Book Section (8)
  4. Correspondence (7)
  5. Review (3)
  6. Conference Paper (1)
  7. Editorial (1)
Groups
  1. Surgery (327)
  2. Urology (327)
  3. Department of Pathology and Laboratory Medicine (134)
  4. Department of Medicine (108)
  5. Solid Tumor Oncology Division (106)
  6. Genitourinary Oncology Service (103)

More Groups

People
  1. Bernard Bochner (166)
  2. Harry Herr (130)
  3. Sherri Donat (96)
  4. Victor Reuter (92)
  5. Dean Bajorin (81)
  6. Hikmat Al-Ahmadie (76)

More People

Years
  1. 2025 (5)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (11)
  5. 2021 (14)
  6. 2020 (16)

More Years

Publications
  1. Journal of Urology (58)
  2. Journal of Clinical Oncology (33)
  3. European Urology (31)
  4. BJU International (20)
  5. Modern Pathology (17)
  6. Laboratory Investigation (16)

More Publications

Publishers
  1. Elsevier Science, Inc. (100)
  2. American Society of Clinical Oncology (35)
  3. Wiley Blackwell (32)
  4. Elsevier Inc. (26)
  5. Nature Publishing Group (21)
  6. American Association for Cancer Research (17)

More Publishers

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy
    Journal Article

    Feuerstein, M. A.; Goldstein, L.; Reaves, B.; Sun, A.; Goltzman, M.; Morganstern, B. A.; Shabsigh, A.; Bajorin, D. F.; Rosenberg, J. E.; Donat, S. M.; more...
    World Journal of Urology (2019)

    Fulltext@MSK | Save
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: Concordance among 3 commonly used and commercially available antibodies
    Journal Article

    Reis, H.; Serrette, R.; Posada, J.; Lu, V.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Sirintrapun, S. J.; Iyer, G.; more...
    American Journal of Surgical Pathology (2019)

    Fulltext@MSK | Save
  • Prognostic value of TERT alterations, mutational and copy number alterations burden in urothelial carcinoma
    Journal Article

    Isharwal, S.; Audenet, F.; Drill, E.; Pietzak, E. J.; Iyer, G.; Ostrovnaya, I.; Cha, E.; Donahue, T.; Arcila, M.; Jayakumaran, G.; more...
    European Urology Focus (2019)

    Fulltext@MSK | Save
  • Reply to Siebren Dijkstra and Carl J. Wijburg's letter to the editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: Oncologic outcomes. Eur Urol 2018;74:465–71. Can the pattern of cancer recurrence truly be assigned to the surgical modality?
    Correspondence

    Bochner, B. H.; Dalbagni, G.
    European Urology (2019)

    Fulltext@MSK | Save
  • Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma
    Journal Article

    Audenet, F.; Isharwal, S.; Cha, E. K.; Donoghue, M. T. A.; Drill, E. N.; Ostrovnaya, I.; Pietzak, E. J.; Sfakianos, J. P.; Bagrodia, A.; Murugan, P.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • The impact of plasmacytoid variant histology on the survival of patients with urothelial carcinoma of bladder after radical cystectomy
    Journal Article

    Li, Q.; Assel, M.; Benfante, N. E.; Pietzak, E. J.; Herr, H. W.; Donat, M.; Cha, E. K.; Donahue, T. F.; Bochner, B. H.; Dalbagni, G.
    European Urology Focus (2019)

    Fulltext@MSK | Save
  • The outcome of post-chemotherapy retroperitoneal lymph node dissection in patients with metastatic bladder cancer in the retroperitoneum
    Journal Article

    Liu, N. W.; Murray, K. S.; Donat, S. M.; Herr, H. W.; Bochner, B. H.; Dalbagni, G.
    Bladder Cancer (2019)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Pre-operative chemotherapy (ctx) in plasmacytoid urothelial carcinoma (PUC)
    Meeting Abstract

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Dalbagni, G.; Bochner, B. H.; Funt, S.; Iyer, G.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save